Showing 13–24 of 72 results

Show sidebar

Elbonix 50

COMPOSITION Elbonix 50 tablet : Each film coated tablet contains EltrombopagOlamine INN equivalent to Eltrombopag 50 mg. Therapeutic class: Hematopoietic Agent PHARMACOLOGICAL

ELOPAG 25 MG

 Elopag Tablet Eltrombopag Olamine 25 mg Everest Pharmaceuticals Ltd. Indications Eltrombopag Olamine is indicated in Chronic Immune (Idiopathic) Thrombocytopenia, Chronic Hepatitis

ELOPAG 50 MG

 Elopag Tablet Eltrombopag Olamine 50 mg Everest Pharmaceuticals Ltd.  Also available as: 25 mg Indications Eltrombopag Olamine is indicated in Chronic

ELTROM 25 MG

DESCRIPTION ELTROM Eltrombopag 25MG Julphar Bangladesh Ltd. Composition: Eltrom Tablet: Each film coated tablet contains Eltrombopag Olamine INN equivalent to

HEPANIB 200 MG

 Hepanib Tablet Sorafenib Tosylate 200 mg Everest Pharmaceuticals Ltd.  Indications Hepatocellular Carcinoma: Sorafenib is indicated for the treatment of patients with

HERNIX 40 MG

 Hernix Tablet Neratinib 40 mg Beacon Pharmaceuticals Ltd. Indications Neratinib is a kinase inhibitor indicated for the extended adjuvant treatment of

IBRUTIX 140 MG

Product Description: Ibrutix (Ibrutinib) is a kinase inhibitor indicated for the treatment of patients with: Mantle Cell Lymphoma (MCL) who

IBRUXEN 140 MG

 Ibruxen Capsule Ibrutinib 140 mg Everest Pharmaceuticals Ltd. Indications Mantle Cell Lymphoma: Ibrutinib is indicated for the treatment of patients with

JUPARIB 150 MG

 Juparib Tablet Olaparib 150 mg Julphar Bangladesh Ltd.  Also available as: 100 mg Indications Breast Cancer: Olaparib is indicated as monotherapy

LAPANIX 250 MG

LAPANIX 250 MG Lapatinib Beacon Pharmaceuticals Ltd. Product Description: Lapatinib, a 4-anilinoquinazoline, is an inhibitor of the intracellular tyrosine kinase